Variantyx is a molecular diagnostics company specializing in advanced genetic testing and diagnostics.
Variantyx has raised $36.0M in total funding. The most recent round was Series D. The last funding was announced in April 2024.
Variantyx's investors include Bosch Ventures, Pitango VC, New Era Capital Partners, Kreos Capital, Peregrine Ventures.
Variantyx is headquartered in Framingham, United States.
Variantyx is a molecular diagnostics company specializing in advanced genetic testing and diagnostics.
Variantyx is at the Series D stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Variantyx — Funding & Investors." VCBacked, April 26, 2024, https://www.vcbacked.co/company/variantyx. Accessed October 29, 2026.
VCBacked. (2024). Variantyx — Funding & Investors. Retrieved October 29, 2026, from https://www.vcbacked.co/company/variantyx
{{cite web |title=Variantyx — Funding & Investors |url=https://www.vcbacked.co/company/variantyx |website=VCBacked |access-date=October 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated